HP
DOCS icon

HealthInvest Partners’s Doximity DOCS Stock Holding History

HealthInvest Partners’s Portfolio DOCS Stock Details DOCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$15.5K Buy
+462
New +$14.1K 0.03% 33

Other funds holding DOCS

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

HealthInvest Partners's DOCS Position: Q4 2022 in Review

HealthInvest Partners opened a new position in Doximity (DOCS) in Q4 2022: 462 shares worth $15.5K. The stake represents 0.03% of the portfolio and ranks #33 among its holdings.

303 funds tracked by Wall St. Rank hold DOCS as of Q4 2022.

  • HealthInvest Partners held 462 shares of Doximity worth $15.5K as of Q4 2022.
  • Doximity was a new HealthInvest Partners position in Q4 2022.
  • Doximity made up 0.03% of HealthInvest Partners's portfolio in Q4 2022, its #33 holding.
  • 303 funds tracked by Wall St. Rank held Doximity as of Q4 2022.

Based on HealthInvest Partners's 13F filing for Q4 2022, filed 14 Feb 2023.